$AMGN Headlines

New Post Public Reply Private Reply Replies (0) Message Board

Nov 20, 2014 at 10:37 AM

$AMGN Headlines

Amgen's stock drops after trial misses secondary endpoint
9:20 a.m. Nov. 4, 2014
- Tomi Kilgore

Amgen's stock drops 2% in premarket trade
9:07 a.m. Nov. 4, 2014
- Tomi Kilgore

Amgen study on cancer treatment misses secondary endpoint
9:06 a.m. Nov. 4, 2014
- Tomi Kilgore

Facebook, Gilead shares fall after hours
6:14 p.m. Oct. 28, 2014
- Sue Chang

Amgen, under investor pressure, outlines strategy
10:05 a.m. Oct. 28, 2014
- MarketWatch.com

Amgen's stock rises after company outlines capital allocation plans
9:07 a.m. Oct. 28, 2014
- Tomi Kilgore

Amgen's stock climbs 3.2% in premarket trade after capital allocation plans
8:55 a.m. Oct. 28, 2014
- Tomi Kilgore

Amgen sees 2015 revenue $20.8 bln-$21.3 bln vs. FactSet consensus $20.33 bln
8:54 a.m. Oct. 28, 2014
- Tomi Kilgore

Amgen sees 2015 adj. EPS $9.05-$9.40 vs. FactSet consensus $9.08
8:53 a.m. Oct. 28, 2014
- Tomi Kilgore

Amgen plans to payout 60% of adj. earnings to shareholders through 2018
8:52 a.m. Oct. 28, 2014
- Tomi Kilgore

Amgen plans to raise dividend 30% starting in Q1 2015
8:52 a.m. Oct. 28, 2014
- Tomi Kilgore

Amgen resumes share buybacks, with plans for $2 bln in repurchases through 2015
8:51 a.m. Oct. 28, 2014
- Tomi Kilgore

‘Dumb money’ unloads bullish oil bets as prices pose threat to stocks
8:35 a.m. Oct. 28, 2014
- Shawn Langlois

4 more ‘Amazon’ stocks you may want to avoid
8:43 p.m. Oct. 27, 2014
- Philip van Doorn

Newscast: Stocks mixed -- barely
6:46 p.m. Oct. 27, 2014
- MarketWatch

Twitter shares drop in wake of quarterly results
5:07 p.m. Oct. 27, 2014
- Sue Chang

Amgen posts strong results on higher sales
4:57 p.m. Oct. 27, 2014
- MarketWatch.com

Updates, advisories and surprises
4:31 p.m. Oct. 27, 2014
- MarketWatch

Amgen net drops, but adjusted earnings beat views
4:14 p.m. Oct. 27, 2014
- Russ Britt

Amgen GAAP net of $1.61 is below $1.81 view
4:06 p.m. Oct. 27, 2014
- Russ Britt

Global drug tab will breach trillion dollar mark this year

7:41 a.m. Today7:41 a.m. Nov. 20, 2014
- Seeking Alpha

Stocks Boosted by Merck’s Vytorin Data

7:25 a.m. Today7:25 a.m. Nov. 20, 2014
- Barrons.com

Positive clinical trial results for alirocumab presented at AHA meeting

12:35 p.m. Nov. 19, 2014
- Seeking Alpha

Hottest Healthcare Stocks Now – ACOR CBPO CELG AMGN

12:00 p.m. Nov. 19, 2014
- InvestorPlace.com

Biotech Stock Roundup: Geron Soars on $935M J&J Deal, Gilead's Harvoni Approved in the EU - Analyst Blog

11:23 a.m. Nov. 19, 2014
- Zacks.com

#PreMarket Primer: Wednesday, November 19: Burst Of Cold Creates Chaos In New York
6:50 a.m. Nov. 19, 2014
- benzinga.com

#PreMarket Primer: Wednesday, November 19: Burst Of Cold Creates Chaos In New York

6:50 a.m. Nov. 19, 2014
- benzinga.com

Pharma Industry Outlook: M&A, Licensing Abound - Zacks Analyst Interviews

1:00 a.m. Nov. 19, 2014
- Zacks.com

Pharma Industry Outlook: M&A, Licensing Abound - Industry Outlook

1:00 a.m. Nov. 19, 2014
- Zacks.com

Gilead's Value Without Its Hep C Franchise

4:07 p.m. Nov. 18, 2014
- Seeking Alpha

Zetia Shows Modest Benefit in Reducing Heart Attacks

5:26 p.m. Nov. 17, 2014
- The Wall Street Journal Interactive Edition

Merck Drug Works: Vytorin Study Proves Successful

12:35 p.m. Nov. 17, 2014
- Investors Business Daily

3 Stocks Moving The Drugs Industry Upward

12:03 p.m. Nov. 17, 2014
- TheStreet.com

Jana Partners 13F Filing Shows Moves In Alibaba & Other Big Names

10:34 a.m. Nov. 14, 2014
- benzinga.com

Regeneron Pharmaceuticals Offers More Upside Than Gilead Sciences

9:23 a.m. Nov. 14, 2014
- Seeking Alpha

AstraZeneca/Amgen's Brodalumab Positive in Psoriasis Trial - Analyst Blog

5:10 p.m. Nov. 13, 2014
- Zacks.com

Amgen Shares Consolidating Ahead Of More Gains?

12:25 p.m. Nov. 13, 2014
- benzinga.com

3 Stocks Underperforming Today In The Drugs Industry

12:06 p.m. Nov. 13, 2014
- TheStreet.com

ARNA Management And Investors Underestimating The Potential Of Belviq And Phentermine Combination

9:52 a.m. Nov. 13, 2014
- Seeking Alpha

10 Must-Own Stocks With Great Earnings, Sales and Guidance

12:15 a.m. Nov. 13, 2014
- InvestorPlace.com

Retrophin Names Margaret Valeur-Jensen, Ph.D. as General Counsel
8:01 a.m. Nov. 19, 2014
- BusinessWire - BZX

Amgen Presents Long-Term Data Showing Efficacy And Safety Of Investigational Cholesterol-Lowering Medication Evolocumab Across Lipid And LDL-C Levels
4:00 p.m. Nov. 18, 2014
- PR Newswire - PRF

Amarantus Enters Into Exclusive Option Agreement to Acquire Engineered Skin Substitute for the Treatment of Severe Burns From Lonza
4:05 p.m. Nov. 17, 2014
- GlobeNewswire

Amgen To Present At The Jefferies Global Healthcare Conference
4:15 p.m. Nov. 14, 2014
- PR Newswire - PRF

Critical Alerts For Caesars Entertainment, Orexigen Therapeutics, Amazon.com, Toyota Motor and Amgen Released By InvestorsObserver
9:31 a.m. Nov. 13, 2014
- PR Newswire - PRF

Biothera Names Carey Anderson VP of Regulatory Affairs
9:30 a.m. Nov. 13, 2014
- BusinessWire - BZX

Amgen To Webcast Investor Call At Upcoming American Heart Association Scientific Sessions
4:35 p.m. Nov. 12, 2014
- PR Newswire - PRF

Amgen To Highlight New Data For Investigational Cholesterol-Lowering Medication Evolocumab
4:01 p.m. Nov. 12, 2014
- PR Newswire - PRF

The Amgen Foundation Expands Amgen Scholars Program to 17 Top Educational Institutions Worldwide
9:00 a.m. Nov. 12, 2014
- PR Newswire - PRF

Amgen And AstraZeneca Announce Positive Results From Second Pivotal Phase 3 Study Of Brodalumab In Patients With Moderate-To-Severe Plaque Psoriasis
4:01 p.m. Nov. 11, 2014
- PR Newswire - PRF

Melanoma Therapeutics Market to 2020 - Rising Prevalence and Evolving Treatment Algorithms to Drive Market Growth
2:24 p.m. Nov. 10, 2014
- PR Newswire - PRF

VYCOR: "On the Cusp of the Next Big Healthcare Trend"
9:23 a.m. Nov. 10, 2014
- ACCESSWIRE

FDA Accepts Amgen's Biologics License Application For LDL Cholesterol-Lowering Medication Evolocumab
9:15 a.m. Nov. 10, 2014
- PR Newswire - PRF

Ziarco Raises $33.1 Million in Series B Financing
7:01 a.m. Nov. 10, 2014
- GlobeNewswire

Collaboration, Breakthrough Therapy Designation, Clinical Trial Data, Voting Rights, and Financial Results - Research Reports on Johnson & Johnson, Merck, Amgen, Shire and HCA
8:50 a.m. Nov. 7, 2014
- PR Newswire - PRF

Amgen To Present At The Credit Suisse Annual Healthcare Conference
4:30 p.m. Nov. 6, 2014
- PR Newswire - PRF

Amgen Highlights New Data In The Treatment Of Blood Cancers At ASH 2014
4:01 p.m. Nov. 6, 2014
- PR Newswire - PRF

Cloud Pharmaceuticals Announces World-Class Board of Directors
8:00 a.m. Nov. 5, 2014
- PR Newswire - PRF

Amgen Announces Top-Line Secondary Endpoint Results Of Phase 3 Trebananib TRINOVA-1 Trial In Patients With Recurrent Ovarian Cancer
9:00 a.m. Nov. 4, 2014
- PR Newswire - PRF

Karyopharm Appoints J. Scott Garland to Its Board of Directors
7:00 a.m. Nov. 4, 2014
- GlobeNewswire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Triller's Tangle: Investors Face Massive Stock Drop

A Descent into Legal Quagmire Investor action notices usually scream trouble, and this time it’s Triller Group Inc. (NASDAQ: ILLR) taking the brunt. If you haven’t been under a rock, you’ve heard they’re in a spot of bother, courtesy of a gnarly combination of financial mishaps and misleading statements. It’s a classic case of a company shooting itself in the...

SINBON's Role in Sustainable Tech Showcase at 2026 Fairs

Get this: What do hospitals, charging stations, and data centers have in common? Well, they all rely on data and power connections that are largely invisible but absolutely fundamental to keeping the gears of modern life grinding. SINBON Electronics is stepping up at electronica and SPS 2026, showing how their nifty gadgets transform mundane wires into the beating heart...

Fosun Drives Global Growth of China's Drug Innovations

A New Phase for Chinese Pharmaceuticals There's a shift in the pharma world, with Fosun International leading the charge. Chinese innovative drugs are stepping onto the global stage, thanks to efforts like those of Chen Qiyu, Co-CEO of Fosun. At the Sustainability Global Leaders Conference 2026, he spoke about transforming Chinese market players into worldwide...

Knexus Teams with Google Cloud to Boost Public Sector AI

Kicking Off a New Era for AI in Government There's a fresh wind blowing in how government agencies approach artificial intelligence, and it’s got Knexus and Google Cloud’s Gemini initiative written all over it. Set in Vienna, Virginia, the announcement rolls out a heavy-hitting collaboration that might just rewire how public sectors handle data. October 20, 2026,...

SQUID Platforms on CDAO Tradewinds Marketplace

Old School Meets New Tech: SQUID's 'Awardable' Moment In an era drowning in data, IESE Solutions throws us a lifeline with its SQUID platform—assessed 'Awardable' and now live on the Department of War's Chief Digital and Artificial Intelligence Office's (CDAO) Tradewinds Solutions Marketplace. Sounds technical, right? Well, let’s dive into why it matters for those...

American Tire Distributors Shifts Gears in Leadership

Another Day, Another Leadership Shuffle at ATD Well, the wheel's turning again at American Tire Distributors (ATD). The crew in Huntersville, N.C., just put Michael Broderick in the driver's seat as Interim President, replacing Ira B. Silver. And they've parted ways with him—done and dusted. This isn't just some random pick; Broderick's been kickin' around ATD's Board...

AppLovin Faces Lawsuit Over AI Claims: Investor Alert

AI Promises or Pipedreams? AppLovin Corporation finds itself in a bit of hot water, and if you've got skin in this game, you've probably felt the heat. So, what's stirring the pot? A class action lawsuit against AppLovin (NASDAQ: APP) for allegedly pulling the wool over investors' eyes with overstated claims about their generative AI tool. Class Action: Weighing the...

JinkoSolar Passes Key Resolutions Amid Name Change

A New Chapter for JinkoSolar Right out of the gate, JinkoSolar has decided to shake things up, along with a new legal identity. The news coming from their 2026 annual general meeting confirms a significant shift in branding from ‘JinkoSolar Holding Co., Ltd’ to the new title of ‘Jinko Holdings Limited’. If you’ve been around the block like me, you’ll know that...

Partner Climbs 25 Spots on ENR's Environmental Firm List

A Leap Forward in Environmental Expertise Alright, folks, let's dive into some real grit. Partner Engineering and Science, Inc. has pulled off a neat little trick. They've jumped up 25 spots on the 2026 Engineering News-Record's Top 200 Environmental Firms list. They’ve been making this list for 14 years straight, and that's no fluke. It's a hard road, especially when...

Fitch Ratings Applauds Ecopetrol's Financial Sturdiness

Ecopetrol: A Rock in Turbulent Waters If you’re looking for a boulder in a sea of pebbles, Ecopetrol’s got the heft. When Fitch Ratings gives a thumbs-up, you best believe they mean it. On October 20, 2026, the rating agency confirmed Ecopetrol’s global credit rating at BB, with a stable outlook, but it’s how they got there that counts. Their standalone credit...